News Detail
New Delhi, 25 Feb 2025: The Central Drugs Standard Control Organization (CDSCO) has issued a final notice to manufacturers of certain pre-1988 permitted Fixed Dose Combinations (FDCs), urging them to submit applications for Phase IV Clinical Trial protocols or Active Post Ma......
View Details
Source : DrugsControl Media Services
Central Drugs Standard Control Organization (CDSCO)
Fixed Dose Combinations (FDCs)
Phase IV Clinical Trial protocols
Active Post Marketing Surveillance
Related News
- Ensure no prescription drugs sold illegally, HC directs CBI, NCB (25-02-2025)
- Drugs & Cosmetics Act: Only Sessions Court Can Try Offences Punishable Under Chapter IV (25-02-2025)
- SC calls for mechanism under law for misleading ads complaints (25-02-2025)
- Maharashtra Medical Council Launches ‘Know Your Doctor’ Platform to Curb quackery (25-02-2025)
- 3 in 5 individuals in India die after cancer diagnosis: Study (25-02-2025)
- International Vaccine Institute launches new biorepository in South Korea (25-02-2025)
- MoU signed for inter-ministerial cooperation for promotion of 'One Herb, One Standard' (25-02-2025)
- 9 more firms had permission to produce now banned drug: Maha FDA (25-02-2025)
- SC Seeks State Responses on ARV Drug Quality Concerns (25-02-2025)
- CDSCO Renames Drug Safety Division to PMDSM (25-02-2025)